Current Research Projects

Project lead: Prof. Chenot /  Dr. Julia Truthmann

Project researchers: Dr. Adrian Richter, Julia Freyer Martins Pereira

Cooperations: Prof. Eva Hummers (Göttingen), Prof. Ildikó Gagyor(Würzburg)

COPAGO investigates the effectiveness and side effects of Prednisolone and Colchicine in the treatment of acute gout attacks in primary care. In collaboration with University Medical Center Göttingen and University Hospital Würzburg, a total of 314 patients with an acute gout attack will be included from over 60 general practices in Greifswald, Göttingen, and Würzburg. The treatment is conducted in a double-blind manner, either with Prednisolone or Colchicine. The aim of the study is to improve the treatment of gout attacks in primary care through evidence-based recommendations. The project is funded by the Federal Ministry of Education and Research.

Read more ... 

The S3-DEGAM Guideline"Care of patients with kidney disease not requiring dialysis in general practice" ("Versorgung von Patienten mit nicht-dialysepflichtiger Nierenerkrankung in der Hausarztpraxis") is currently getting updated with the financial support by GBA.

Read more...

In order to improve the timely care of patients with neurological diseases in the outpatient sector in Western Pomerania, a telemedical network is being established in the region between GP practices and the Department of Neurology at the university hospital of Greifswald. Patients with neurological diseases present themselves virtually to the Neurology department directly from their GP consultation. For this purpose, the Greifswald Neurology Clinic offers an immediately accessible specialist consultation during regular consultation hours. This way, the on-site care of patients in the GP practices is strengthened and thus regional care is facilitated.

Read more ...

Project lead: Prof. Dr. Carsten Oliver Schmidt

Project researchers: Prof. Dr. Jean-Francois Chenot, Dr. Elisa Kasbohm, Dr. Julia Truthmann

The overall aim of the TARISMA network (Targeted Risk Management in Musculoskeletal Diseases) is to identify risk factors for inadequate care of people with inflammatory and non-inflammatory musculoskeletal diseases and to develop approaches for better care of specific risk groups. The common research question is what influence vulnerable life phases or multimorbidity have on the course of care and the utilisation of care services, and how any possible resultant underuse can be countered.

Read more ...